| [May 03, 2007] |
 |
2007 BIO International Convention Exhibitor Profiles Continued, D through M
BOSTON --(Business Wire)-- 2007 BIO International Convention, the Global Event for Biotechnology, takes place May 06 - 09, 2007 at the Boston Convention & Exhibition Center. For in-depth information about the event, visit http://www.bio2007.org/Media/releases.html.
Below are profiles from BIO exhibitors, listed D through M.
Business Wire is the official news wire for 2007 BIO International Convention. Breaking news releases and photos are available at Tradeshownews.com, Business Wire's trade show, conference, and event news resource as well as the official show site.
Company: D-Pharm Ltd
Media Contact: [email protected]
Phone: 97289385100
E-mail: [email protected]
Web: www.dpharm.com
D-Pharm Ltd is a clinical stage company focused on discovery and
development of lipid-based therapeutics for CNS disorders and cancer.
D-Pharm's most advance product, DP-b99, recently successfully
completed a Phase IIb study in acute stroke patients. DP-b99 was
found to double the chance to fully recover following stroke. These
results will be described by D-Pharm's President and CEO at the Bio
2007 Business Forum in Boston on Wednesday May 9th, Room A at 9.00am.
D-Pharm's other pipeline products include DP-VPA (Phase II) for
epilepsy, migraine and bipolar disorder and DP-460 (preclinical) for
Alzheimer's disease. Visit www.dpharm.com.
Company: Dry Ice Corp.
Booth: 600
Media Contact: Pat Walsh
Phone: 410-536-4939
E-mail: [email protected]
Web: www.dryicecorp.com
Dry Ice Corp. is the largest regional supplier of dry ice products and
customized delivery services in the Northeastern U.S. We specialize
in supplying the Biotech, Pharmaceutical, and Research industries
with a reliable supply of "fresh" dry ice and on-site "desk-top"
delivery services.
From Maine to Virginia, you can count on Dry Ice Corp. to provide
uninterrupted supply of essential dry ice from one of our six
branches located in; Boston, MA-Branford, CT- Newark, NJ-New York
City, NY-Philadelphia, PA and Baltimore, MD.
Visit our web-site at www.dryicecorp.com to learn more about our Total
Dry Ice Supply Programs.
Company: DSM Pharmaceutical Products
Booth: 3021
Media Contact: Terry Novak
Phone: 973-257-8471
E-mail: [email protected]
Web: http://www.dsmpharmaceuticals.com
DSM Pharmaceutical Products is a global provider of high quality
custom contract manufacturing services to the pharmaceutical and
biopharmaceutical industries. DSM Pharmaceutical Products provides
contract manufacturing services including: advanced intermediates,
active ingredients (API's), amino acids and derivatives, mammalian
cell culture production (fed-batch and perfusion) of monoclonal
antibodies, proteins, vaccines, finished dose manufacturing of solid
dose, scheduled drugs, liquids, aseptic liquid and lyophilized
products.
From clinical to commercial services, DSM focuses the right resources
on providing the highest level of service and quality while applying
innovative solutions to satisfy customers' unique manufacturing
needs.
Company: Dynogen Pharmaceuticals, Inc.
Media Contact: Heather Savelle
Phone: 781.839.5149
E-mail: [email protected]
Web: www.dynogen.com
Dynogen is a clinical-stage company developing a portfolio of
treatments for gastrointestinal and genitourinary disorders. The
Company is focused on attractive and untapped markets in disease
areas that severely impair a patient's quality of life, such as
irritable bowel syndrome (IBS), gastroesophageal reflux disease
(GERD) and overactive bladder (OAB). Dynogen leverages its
development expertise to identify promising clinical compounds and
rapidly advance them towards registration.
Dynogen currently has three clinical stage products in various stages
of development for five indications:
--DDP733 for IBS with constipation (IBS-c) and NGERD
--DDP225 IBS with diarrhea (IBS-d) and OAB
--DDP200 for OAB
Company: Economic Development Board, Singapore
Booth: 2533
Media Contact: Sheo Shanker Rai
Phone: 65 6395 7784
E-mail: [email protected]
----------------------------------------------------
Web: www.biomed-singapore.com
----------------------------------------------------
The Economic Development Board is Singapore's lead agency responsible
for planning and executing strategies to sustain Singapore's position
as a compelling global hub for business and investment. The
Biomedical Sciences Group oversees the development of Singapore's
biomedical sciences industry and supports biomedical sciences
companies with manufacturing, research and development, headquarter
and other high-value operations in Singapore. www.biomed-
singapore.com
Company: Economic Development San Marcos
Booth: 3065
Media Contact: Kim Moore
Phone: 512-393-3400
E-mail: [email protected]
----------------------------------------------------
Web: www.ecodevsanmarcos.org
----------------------------------------------------
Economic Development San Marcos (EDSM) is a division of Global
Marketeer Group, Inc. under contract with the City of San Marcos,
Texas. EDSM serves as a catalyst for job creation, job retention and
business investment. San Marcos is located between Austin and San
Antonio on Interstate Highway 35 providing interstate and
international travel. Location, infrastructure, and market access
make San Marcos a successful community for business and industry.
Texas State University-San Marcos is the largest university of the
Texas State University System with over 27,500 students. Texas State
provides a well-trained workforce for the region's growing high tech
industry.
Company: EBD Group
Booth: 1059
Media Contact: Constantine Theodoropulos
Phone: 617-619-9801
E-mail: [email protected]
Web: www.ebdgroup.com
EBD Group is the leading partnering firm for the global biotechnology
industry. Since 1993, firms in the life sciences have leveraged EBD
Group's partnering conferences, technology and services to identify
business opportunities and develop strategic relationships that drive
their business.
EBD Group's conferences (run in collaboration with leading industry
partners and international trade associations such as BIO and
Eucomed) include BIO-Europe, BIO-Europe Spring, BioEquity Europe (co-
organized with BioCentury Publications); and the medical technology
and BioDevice Partnering. EBD's novel web-based partnering software
system is also used at numerous third-party events around the world.
Outside of the conference format, EBD Group's consultants provide
hands-on assistance for firms seeking to in- or out-license products
and technologies.
Company: Eden Biodesign
Booth: 3225
Media Contact: Stephanie Monfront
Phone: 0207 861 3838
E-mail: [email protected]
Web: www.edenbiodesign.co.uk
Eden Biodesign is a world leader in the provision of biopharmaceutical
development and manufacturing expertise and now operates the new
world class UK National Biomanufacturing Centre.
The combination of the advanced facility and the expertise found in
its people, mean Eden Biodesign has the scope and the capacity to
handle over 95% of the products and processes found within the
biopharmaceutical pipeline.
--Recombinant protein therapies (antibodies and fragments)
--Natural proteins
--Gene therapies
--Cell therapies
--Vaccines (VLP, Cancer vaccines, whole cell vaccines)
--Tissue
engineering
Company: Embera NeuroTherapeutics, Inc.
Booth: 1725 - Louisiana Pavilion
Media Contact: Stephanie Martin
Phone: (318) 213-0198
E-mail: [email protected]
Web: www.emberaneuro.com
Embera NeuroTherapeutics is a specialty pharmaceutical company
dedicated to developing and commercializing novel treatments for a
broad range of addictions and neuropsychiatric disorders. Embera is
preparing to enter clinical trials for EMB-001, a patent-pending drug
combination developed for the treatment of addiction and psychiatric
disorders. EMB-001 targets the specific neurological pathways
associated with craving and relapse and may be effective in treating
a wide array of addictions including cocaine, methamphetamine, and
alcohol dependence as well as psychiatric illnesses such as anxiety
and compulsive behavioral disorders. For additional information
regarding EMB-001 and Embera NeuroTherapeutics please visit the
company's website: http://www.emberaneuro.com.
Company: EMC Corporation
Booth: Booth #533, Pod #A3
Ticker Symbol & EMC, NYSE
Exchange:
Media Contact: Hadley Weinzierl
Phone: 508 293 7642
E-mail: [email protected]
Web: www.emc.com
EMC Corporation is the world's leading developer and provider of
information infrastructure technology and solutions that enable life
sciences organizations of all sizes---from pharmaceutical,
biotechnology, and medical device, academic research labs, to
government organizations --- to transform the way they create value
from their information.
EMC representatives will discuss and demonstrate how life sciences
organizations can store information more intelligently, leverage
content for collaboration and compliance, protect information
effectively and affordably, and secure critical assets. EMC will also
discuss its information archiving and compliance solutions for
emerging and enterprise life sciences organizations.
Company: Empyrean Management Group
Booth: 2700
Media Contact: Kristy Boldt
Phone: 610-275-4400
E-mail: [email protected]
Web: www.HireSmartPeople.com
Empyrean Management Group, Inc. (EMG) is a Management Consulting
company focused on the most important aspect of any organization, its
people. EMG provides Fixed Price/Fixed Time outsourced HR,
Recruiting, and Training services on a national basis for clients
ranging from Fortune 50 companies to emerging and midsize businesses
spanning across many industries. EMG facilitates the design and
implementation of systems that attract and retain the best possible
employees for our clients.
Inc. Magazine and the Philadelphia Business Journal have recently
recognized EMG as one of the fastest growing privately held companies
in the US and Philadelphia, PA regions.
Company: Enterprise Honolulu (Economic Development, Hawaii)
Booth: 687
Media Contact: Mark Ritchie
Phone: (808) 521-3611 x11
E-mail: [email protected]
----------------------------------------------------
Web: http://www.enterprisehonolulu.com
----------------------------------------------------
Enterprise Honolulu is a private sector economic development
organization. We assist life science and other technology companies
to grow in Hawaii and to develop global markets. Working with our
partner organizations we offer Hawaii companies a range of services,
including business planning, financing and business development and
expansion assistance. Also, we assist mainland and international
companies exploring investment locations for life science projects.
Our organization can provide site selectors a wealth of information
on Hawaii's competitive advantages as well as coordinate a range of
additional services to companies establishing operations in Hawaii.
Company: ERA Consulting Group
Booth: 774 & 1864
Media Contact: Mr. Paul Cronin
Phone: 44-20-7510-0200
E-mail: [email protected]
Web: www.eraconsulting.com
The ERA Consulting Group provides regulatory affairs and product
development consulting services, specializing in strategies for
biotech and other biological products. We have offices in Germany
(near Hannover), UK (London), USA (Washington D.C.) and Australia
(Brisbane). Our experience covers over 250 products with input
ranging from feasibility studies and advice on regulatory strategy,
to the compilation and submission of complete dossiers. Our clients
range from virtual biotech companies to the largest pharmaceutical
corporations. Our 20-year track record places us in an unrivalled
position in this specialized field and provides a level of expertise
from which all clients can benefit.
Company: EuropaBio
Booth: 781
Media Contact: Adeline Farrelly, Communications Director
Phone: 32 2 735 0313
E-mail: [email protected]
Web: www.europabio.org
EuropaBio's mission is to promote an innovative and dynamic
biotechnology-based industry in Europe.
EuropaBio (the European Association for Bioindustries) has 78 direct
members operating Worldwide, 12 associate members and 5 bioregions as
well as 25 national biotechnology associations representing some 1800
small and medium sized enterprises involved in research and
development, testing, manufacturing and distribution of biotechnology
products.
Company: European Pavilion
Booth: 773
Media Contact: Stephane Hogan
Phone: 32 2 296 2965
E-mail: [email protected]
Web: www.ec.europa.eu/research/eu-bio2007
The EU Joint Delegation at BIO 2007 consists of experts and high level
policy makers from the European Commission, the executive arm of the
EU, the European Patent Office (EPO) and the European Medicines
Agency (EMEA). Through its participation in the BIO International
Convention, the EU Joint Delegation will present current developments
in biotech in the EU relevant for the global industry: policy,
regulation, scientific cooperation and funding. It will be headed by
Mr. John Bruton, the European Union Ambassador to the USA. The EU
Pavilion (booth number 773) features representatives of the EC, EMEA
and EPO.
Company: Evotec
Booth: UK Pavillion - Booth 1660 & German Pavillion - Booth
555
Ticker Symbol & EVT
Exchange:
Media Contact: Sarah Herrmann
Phone: 0207 867 3838
E-mail: [email protected]
Web: www.evotec.com
Evotec AG (FSE: EVT) is a leader in the discovery and development of
novel small molecule drugs. The Company has built a powerful platform
that is applicable to targets across all therapeutic areas and has
specific expertise in the area of Central Nervous System (CNS)
related diseases where it is building a pipeline of drug candidates
for partnering.
Through its collaborations and proprietary projects Evotec is
providing the highest quality research results to its partners:
--In proprietary projects, Evotec specialises in finding new
treatments for diseases of the Central Nervous System.
--In collaborations, Evotec has established itself as the partner of
choice for pharmaceutical and biotechnology companies worldwide.
Company: Favrille, Inc.
Ticker Symbol & Nasdaq: FVRL
Exchange:
Media Contact: Pete De Spain
Phone: (858) 526-2426
E-mail: [email protected]
Web: www.favrille.com
Favrille, Inc. is a biopharmaceutical company focused on the
development and commercialization of targeted immunotherapies for the
treatment of cancer and other diseases of the immune system. The
Company's lead product candidate, FavId, is based upon unique genetic
information extracted from a patient's tumor. FavId is currently
under investigation in a pivotal Phase 3 clinical trial for patients
with follicular B-cell NHL and Phase 2 clinical trials in other B-
cell NHL indications. The Company is developing additional
applications based on its immunotherapy expertise and proprietary
cost-effective manufacturing technology, including a second product
candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.
Company: FLAMMA Sas
Booth: 2025 - Italy Pavilion
Phone: 33 1 55 52 14 50
E-mail: [email protected]
Web: www.flamma.it
FLAMMA is a manufacturer founded in 1950 and based in Bergamo/Italy
with specific expertise in the field of AA derivatives & related
compounds. Company expertise ranges from the production of AA
derivatives classified as starting materials/key intermediates, to
the related compounds classified as active pharmaceutical
ingredients.
Currently FLAMMA operates also in France with the marketing subsidiary
Flamma sas and in P.R. China with the manufacturing joint-venture
Flamma Gongan Biochemicals Co. Ltd for the production of some basic
amino-acids and with a fully owned Research & Technology Center in
Shanghai, Shanghai Flamma Bioscience Co. Ltd.
Company: Florida Biologix
Booth: 1743 Florida Pavillion
Media Contact: Jim Ayala- Director of Business Development
Phone: 386-418-8199 ext 203
E-mail: [email protected]
Web: www.floridabiologix.ufl.com
Florida Biologix is non-profit Contract Manufacturing Organization
(CMO) that offers a wide range of biopharmaceutical development and
manufacturing services to the biotechnology industry and to
biomedical research institutions, including: cell line engineering,
cGMP cell banking, upstream and downstream processes design, process
and assay development, cGMP production of proteins expressed in
mammalian cells (including monoclonal antibodies, recombinant
proteins, enzymes, vaccines, and other biomolecules), purification,
aseptic filling (including small molecules, nucleic acids, and
proteins), product testing, and regulatory support. Products made in
this facility are suitable for pre-clinical, and Phase I and II human
clinical trails.
Company: Florida High Tech Corridor Council
Booth: 1743
Media Contact: Justin Campfield
Phone: (407) 423-8006
E-mail: [email protected]
Web: www.FloridaHighTech.com
The Florida High Tech Corridor Council (FHTCC) is an economic
development initiative of the University of Central Florida, the
University of South Florida and the University of Florida whose
mission is to attract, retain and grow high tech industry in the 23-
county Corridor.
A partnership of more than 20 local and regional economic development
organizations (EDOs) and 14 community colleges, FHTCC employs a
strategic approach to high tech economic development that involves
matching funds research, workforce development and a marketing
program leveraging governmental, EDO and corporate budgets on a
regional rather than local basis.
Company: Foamix Ltd.
Booth: 3171
Media Contact: Dov Tamarkin
Phone: 972-8-9316233
E-mail: [email protected]
----------------------------------------------------
Web: www.foamix.co.il
----------------------------------------------------
Foamix develops proprietary topical foam products for dermatology,
gynecology, wound and burn care. By incorporating drugs in foam, we
create premium products with improved convenience, higher compliance
and better efficiency of treatment. We currently collaborate with 8
pharmaceutical companies in the development of proprietary foam
drugs; and we have our in-house pipeline of dermatological and
gynecological drugs in foam.
The Foamix foam delivery platforms include:
1. Oil in water emulsion foam (cream-like)
2. Water in oil emulsion foam (occlusive-cream-like)
3. Waterless hydrophilic foam (hydrophilic-ointment-like)
4. Oily foam (with or without water)
5. Petrolatum based foam (ointment-like)
6. Suspension foam
Company: Formatech, Inc.
Booth: 533-D7
Media Contact: Jeffrey Bernard
Phone: 978-725-9077
E-mail: [email protected]
Web: www.formatech.com
Formatech is a dedicated contract service provider that excels
delivering unique solutions to our client's product development and
manufacturing challenges.
Our development services include preformulation & formulation
development of all common dosage forms, cell culture/fermentation
development and purification/downstream process optimization.
Developing biotherapeutic products is one of Formatech's strengths.
Our accomplishments include developing Ab formulations at
concentrations in excess of 200 mg/mL and an orally bioavailable
peptide formulation.
Our aseptic manufacturing facility produces liquid & lyophilized
dosage units for clinical supplies or small scale commercial
products. Manufacturing support services include
compounding/formulation, diafiltration/concentration (UF/DF), release
testing, and full ICH Guideline Stability Programs.
Company: Fritz Gyger AG
Booth: 1919, Swiss Biotech Pavilion
Media Contact: Barbara Rohner-Gunziger
Phone: 41 (0)33 336 22 77
E-mail: [email protected]
Web: www.fgyger.ch
Fritz Gyger AG was founded in 1959 in Switzerland.
Since 1992, High Speed Micro Solenoid Valves have been developed and
produced, with ultra-hard materials as their key elements. The newest
generation of modular SMLD valves find their application for example,
in the fields of analysis technology and nano litre dispensing
devices. The technology of Gyger sets new standards with reference to
miniaturization, liquid metering accuracy and lifetime.
The development and manufacturing of functional modules for HPLC pumps
makes Gyger a strong partner in this field.
Gyger offers a service to fulfil the need of customised solutions for
micro dispensing systems.
Company: Frontier BioSciences, Inc.
Booth: 688
Media Contact: Beth Wong, AVP, Business Development
Phone: 240-372-2100
E-mail: [email protected]
Web: http://www.frontierbsi.com/
Frontier BioSciences, Inc. is a MD-based company providing preclinical
CRO services in Chengdu, China. With its partner, the National
Chengdu Center for Safety Evaluation of Drugs, it provides
preclinical toxicology services, including PK/TK, Animal Models,
General Toxicology, Developmental & Reproductive Toxicology, Safety
Pharmacology, and Genetic Toxicology, supported by in-house
bioanalytical, clinical pathology, and histopathology services. The
state-of-the art toxicology facilities encompass 80,000 sq. ft. and
are equipped with the latest advanced technology and are operated by
highly-trained and experienced staff with international CRO
experience.
Company: Fundacion Biociencia
Booth: 2771 Chile Pavilion
Media Contact: Olivier Rickmers
Phone: 56 2 343 25 78
E-mail: [email protected]
Web: www.bioscience.cl
High-Knowledge Institution specialized on Extremophiles R&D.
Company: Fusion Antibodies
Booth: 1875
Media Contact: Dr Paul Kerr
Phone: 4477929734619
E-mail: [email protected]
Web: www.fusionantibodies.com
Fusion Antibodies is a biotechnology company focused on the discovery,
development and commercialisation of antibody-based therapeutics for
cancer & angiogenesis.
Fusion also provides contract services for the rapid expression &
purification of recombinant proteins, antibody sequencing and
antibody engineering for the research, diagnostic and therapeutic
markets.
Company: Genome Prairie
Booth: #823 - Manitoba-Canada Pavilion
Media Contact: Carol Reynolds
Phone: (306) 241-9033 / cell (306) 668-3574
E-mail: [email protected]
----------------------------------------------------
Web: www.genomeprairie.ca
----------------------------------------------------
Genome Prairie (www.genomeprairie.ca) is the leading organization for
support and management of large-scale genomics and proteomics
research projects in Manitoba and Saskatchewan, Canada. With its
partners, Genome Prairie has supported more than $120 million of
research activity in plant, animal and human genomics,
bioinformatics, instrumentation development and bioethics since 2000.
Current research projects led by Genome Prairie include the North
American Conditional Mouse Mutagenesis (NorCOMM) Project
(www.norcomm.org) and the Crop Adaptation Genomics Project
(www.cropadaptationgenomics.ca) involving frost-tolerant wheat.
Genome Prairie works collaboratively with all levels of government,
universities and industry provincially, nationally and
internationally to advance genomics and proteomics research.
Company: genOway
Booth: French pavilion-1207
Phone: 33 437 65 41 00
E-mail: [email protected]
Web: www.genOway.com
Operating in Europe, North America and Asia, genOway proposes time
saving and cost effective strategies for in vivo drug development
programs. Focusing its effort on the mouse and rat, genOway has
developed a complete range of innovative technological solutions to
create a new generation of customized transgenic models. genOway's
expertise combines technologies classically used in transgenesis and
several cutting-edge proprietary technologies aiming at enhancing the
efficiency, security and relevance of the tailor-made animal model
ultimately developed.
Moreover, genOway license policy allows his clients to have a free use
of the model developed for target validation and drug discovery
purposes.
Company: GenScript Corporation
Booth: 1023
Phone: 732-885-9188
E-mail: [email protected]
----------------------------------------------------
Web: www.genscript.com
----------------------------------------------------
As a pioneer of the life science research service industry, GenScript
Corporation has developed, reliable and innovative techniques, rock-
solid quality control, and a one-stop service package that provides
quality gene, peptide, protein, and antibody products and services at
competitive prices. Our services include gene synthesis, cloning and
mutagenesis, protein expression and purification, antibody
production, and gene functional analysis.
GenScript's business philosophy has always been to satisfy the
customer's needs through adaptation and experience. GenScript is
proud to participate in the 2007 BIO International Convention and
looks forward furthering partnerships with customers, business peers,
and other members of the biotechnology community.
Company: GlaxoSmithKline Biopharmaceuticals
Booth: 1160
Ticker Symbol & GSK
Exchange:
Media Contact: Anthony J Zuazo
Phone: 610 239 3887
E-mail: [email protected]
Web: www.gsk.com/biopharm
GSK Biopharmaceuticals is a full-service provider in the development
and cGMP preparation of biopharmaceutical proteins for clinical
trials and the marketplace. Our services include the low-cost, rapid
scale-up and manufacture of mammalian cell derived proteins at up to
5,000L scale and the preparation of formulated bulk products.
Company: GLW Storing Systems
Booth: 658
Media Contact: Mrs. Astrid Hartenstein
Phone: 49 931 6677 210
E-mail: [email protected]
Web: www.glw-storingsystems.com
GLW is a privately owned company in Northern Bavaria, specialized in
sample storage systems (plastics, metal) for long-term storage, deep
freezing and transportation.
Company: GlycoGene, Inc.
Booth: 2549-Japan Pavilion
Media Contact: Tadayoshi Kawasaki, Ph.D., President & CEO
Phone: 81-(0)29-855-1080
E-mail: [email protected]
Web: http://www.glycogene.co.jp
We can provide services of 1) Oligosaccharide synthesis, 2)Glycan
analysis, 3)Screening of Biomarkers, 4) Glyco-engineering, and 5)
Biopharmaceutical development by modifying the glycans.
GlycoGene, Inc., will provide services of Oligosaccharide synthesis,
either N-glycan or O-glycan by use of over 180 human
glycosyltransferases. Also we can provide services of glycan analysis
of glycoproteins. We also are working on the Screening of Biomarkers
which related to glycan, glycosyltransferases and the genes. We are
interesting to have collaboration with pharmaceutical companies to
develop a biopharmaceuticals with use of Glyco-engineering, either a
new one or a biosimilar.
Company: Glycotope GmbH
Booth: 565
Media Contact: Dr. Hans Baumeister
Phone: 49-(0)30 941 084 207
E-mail: [email protected]
Web: www.glycotope.com
Glycotope - the GlycoEngineering Company - has specialized in
exploring the glycosylation machinery and health related significance
of sugar structures on proteins and on microorganisms. Based on
GlycoExpress, a proprietary human cell-line to generate fully human
glycosylated proteins with optimized sialylation degrees, we develop
own glycoproteins for therapeutic use, tumor specific antibodies and
vaccines, as well as nutraceuticals with specific health
characteristics. Furthermore, the company offers services in form of
integrated glycoengineering and antibody engineering solutions.
Company: Government of Canada BioPortal
Booth: Booth #815 / Government of Canada Pavilion
Media Contact: Joshua Belinko
Phone: 613-954-7737
E-mail: [email protected]
Web: http://biotech.gc.ca
The highly acclaimed Government of Canada BioPortal is designed for
scientists, researchers, business people, consumers, regulators, and
anyone interested in biotechnology. It is the definitive source for
information on Canada's biotechnology regulations, investment and
business opportunities, government policies and research activities,
public opinion, and consultation activities on key issues. See
http://biotech.gc.ca.
Company: GP Pharm
Booth: 988
Media Contact: Xavier Verges
Phone: 0034936388000
E-mail: [email protected]
Web: www.gp-pharm.com
GP Pharm is located in Barcelona (Spain). Our activities are focused
on development of injectable products within Urology and Oncology
fields, some based in own Drug Delivery Systems. These technological
platforms include microspheres and liposomes.
The company works in the complete development of these drugs, from
preclinical studies until the launch to the market. These
specialities will be marketed either under own brands or through
licenses. The new production plant of GP Pharm recently achieved EU
GMP approval and started manufacturing operations, being also
designed to be FDA GMP approved.
Company: Greater Dallas Chamber Technology Business Council
Media Contact: Jo Trizila
Phone: 214-746-6690
E-mail: [email protected]
Web: www.DallasTBC.org / www.BioDFW.org
The Greater Dallas Chamber's Technology Business Council promotes
Dallas/Fort Worth as a world-class technology center and provides the
region with a vehicle to effectively assemble all parties related to
its technology resources and infrastructure. This objective supports
the Chamber's overall mission of enabling continual business growth
throughout North Texas while helping the region maintain its
technology preeminence on a national scale. There are a host of
issue-specific council groups, events and affiliated opportunities
for participation through the Technology Business Council investment.
For more information, please visit www.DallasTBC.org or contact
[email protected].
BIODFW fosters an open, entrepreneurial environment that encourages
growth and innovation; develops an information clearinghouse of
relevant regional resources in the life sciences; and supports
regional economic development endeavors in the life science arena.
BioDFW's goal is to be the primary vehicle that establishes the North
Texas region as a global competitor in the life science industry and
to foster an ideal climate for entrepreneurs, researchers, industry
management and staff, faculty, students and related business
suppliers. BIODFW offers a monthly breakfast series featuring keynote
speakers focused on business issues and opportunities in the life
science industry. For more information on BioDFW's initiatives,
please visit www.BioDFW.org.
Company: Greater Phoenix Economic Council
Booth: Arizona Pavilion - Booth #2255
Media Contact: Linda Brady
Phone: 602-350-8809
E-mail: [email protected]
Web: www.gpec.org
Greater Phoenix's diverse economic base, highly skilled workforce and
strong business climate position us firmly among the most competitive
regions in the world.
When you are faced with obtaining the facts you need to make the right
decision on relocating or expanding your business, GPEC is your
resource.
Our team of expansion and relocation specialists confidentially help
you obtain all the facts you need to thoroughly evaluate the region.
We save you countless hours of research and analysis by providing a
full complement of services, all at no cost or obligation to you.
Contact GPEC for more information: 800.421.4732.
Company: Greater Tampa Chamber of Commerce
Booth: 1743 (Enterprise Florida Pavilion)
Media Contact: Chris Smith, Vice President Public Policy
Phone: (813) 276-9455
E-mail: [email protected]
Web: http://www.tampachamber.com/economic_development.asp
The Greater Tampa Chamber of Commerce Committee of One Hundred (C100)
is Tampa/Hillsborough County's official economic development
partnership, funded by Hillsborough County, the cities of Tampa,
Plant City, and Temple Terrace, and private sector investors. C100
provides confidential site selection services for life science
business expansion and relocation projects.
http://www.tampachamber.com/economic_development.asp[FEED_CR
LF]Company: GTC Biotherapeutics
Booth: # 533 / Pod# 23
Ticker Symbol & GTCB
Exchange:
Media Contact: Thomas Newberry
Phone: 508-370-5374
E-mail: [email protected]
----------------------------------------------------
Web: www.gtc-bio.com
----------------------------------------------------
GTC Biotherapeutics develops, produces, and commercializes therapeutic
proteins through transgenic animal technology. ATryn(R), our
recombinant form of human antithrombin, is the first transgenically
produced protein to be approved anywhere in the world, having
recently been approved by the European Commission for the
prophylactic treatment of deep vein thrombosis in patients with
hereditary antithrombin deficiencies that are undergoing surgical
procedures. In addition to ATryn(R), GTC is developing additional
recombinant forms of therapeutic proteins normally found in human
blood plasma as well as monoclonal antibodies. These products have
potential applications in hematology, oncology, and autoimmune
diseases. Additional information is available at http://www.gtc-
bio.com.
Company: Hawaii Life Sciences
Booth: 687
Media Contact: Elizabeth Corbin
Phone: (808) 255-1560
E-mail: [email protected]
Why Hawaii? Unique marine & terrestrial biodiversity throughout the
Hawaiian islands; Outstanding capability for biofuels development;
Ethnically diverse state, ideal for clinical trials; Excellent work
force; Venture capital availability; Nation's most generous high
technology investment and R&D tax incentives; Strategic Asia-Pacific
location.
Company: HealthCare Institute of New Jersey
Booth: New Jersey Pavilion
Media Contact: William Healey/EVP or Hollie Gilroy, Director of
communications
Phone: 908-334-7229(Healey) or 908-212-0333 (Gilroy)
E-mail: [email protected] / [email protected]
Web: www.hinj.org
The HealthCare Institute of New Jersey (HINJ) is headquartered in
Bridgewater, in the heart of the Garden State's pharmaceutical and
medical technology core.
HINJ represents 33 of the largest researched-based pharmaceutical and
medical technology firms, virtually all of whom call NJ their world
or North American headquarters. HINJ members employ more than 60,000
persons in the state and 100,000 indirectly in spin-off jobs.
Company: Helix BioMedix, Inc.
Ticker Symbol & OTCBB: HXBM
Exchange:
Media Contact: Alison Ziegler, Investor Relations
Phone: 212-554-5469
E-mail: [email protected]
Web: www.helixbiomedix.com
Helix BioMedix, Inc. is a biopharmaceutical company with a vast
library of diverse bioactive peptides. The company's mission is to
enrich clinical practice and the patient and consumer experience by
expanding opportunities to tap the health, beauty and safety benefits
of advanced bioactive small molecule technology. Our vision is to be
recognized as the world leader in the identification, qualification
and commercialization of natural and synthetic peptide technology.
Applications for Helix BioMedix peptides include anti-aging
cosmeceutical skin care, acne treatment and other topical anti-
infective pharmaceuticals and wound healing. More information may be
found on the company's website at www.helixbiomedix.com.
Company: HENOGEN SA
Booth: 2480
Media Contact: Marc Gesnot
Phone: 32 71 34 79 00
E-mail: [email protected]
Web: www.henogen.com
Henogen is a multipurpose biotech facility addressing bio-
manufacturing issues and has extensive knowledge in performing and/or
accompanying partners through the process development and cGMP
production up to phase III.
--cGMP BL2/BL3 facilities including fill and finish.
--European-wide agreement No. 1535 for manufacturing pharmaceutical
products.
--Track records: r-proteins, subunit and live attenuated vaccines,
monoclonal antibodies, viral vectors,
--"Elite European Company" (critical/comparative study of Biotech
Companies, EuropaBio 2006).
Bio-manufacturing
capabilities:
--Microbial
fermentation (150L).
--Mammalian & Insect cell culture (80L perfusion, 300L fed batch).
--Virus
production.
Company: High Resolution Engineering
Booth: 3058
Media Contact: Ann Bellinger
Phone: 781 932 1912
E-mail: [email protected]
Web: www.hireseng.com
High Resolution Engineering provides world class engineering services
for the life science community. Our MicroCell is designed for
unmatched reliability and features self identifying, dockable carts
paired with innovative docking stations. Our multithreading, dynamic
scheduling algorithm, Cellario will improve your assay scheduling
timings and is easy to use.
Company: HistoRx, Inc.
Booth: 1371
Media Contact: John Tonkinson, PhD
Phone: 203-498-7500 x220
E-mail: [email protected]
Web: www.historx.com
HistoRx analyzes biomarkers in situ using a platform capable of
measuring biomarker concentration with subcellular resolution in
tissue sections and tissue microarrays. HistoRx forms partnerships
with pharmaceutical companies to develop biomarker assays and
companion diagnostic tests. With the results from AQUA(R) analysis
scientists have, for the first time, highly quantitative,
standardized and reproducible IHC results. HistoRx sells the PM-
2000(TM) instrument and AQUA(R) software, the most advanced
quantitative fluorescent immunohistochemical analysis of tissue
microarrays/sections available, to academic and not-for-profit
research institutions for noncommercial use. With proprietary AQUA(R)
algorithms, the guesswork is taken out of IHC.
Company: Health Protection Agency
Booth: 1776
Media Contact: Dr Phil Luton
Phone: 44 (0) 7887 656001
E-mail: [email protected]
Web: www.hpa.org.uk/business
The UK's Health Protection Agency was formed in 2003 to provide a
coordinated response to emerging chemical, radiological and
biological health threats, including the threat of bioterrorism. The
Agency has over 3000 staff in 3 national Centres, as well as at
regional and local levels who work to "Protect People, Prevent Harm
and Prepare for Threats".
We undertake research and development of vaccines and therapeutics
against infectious diseases, including work for the US National
Institute of Allergy & Infectious Diseases, as well as testing of
diagnostics, the running of emergency training exercises and the
manufacture a number of healthcare products.
Company: Hydra Biosciences
Media Contact: Russell Herndon
Phone: 617 494 5230
E-mail: [email protected]
----------------------------------------------------
Web: www.hydrabiosciences.com
----------------------------------------------------
Hydra Biosciences is a development stage biopharmaceutical company
based in Cambridge, Massachusetts. Hydra is developing novel small
molecules for the treatment of pain, inflammation, cardiovascular and
other diseases by focusing on a new target class: Transient Receptor
Potential (TRP) ion channels. The TRP superfamily is a recent
discovery and Hydra's team includes the world-leaders in
electrophysiology and TRP channel biology. Hydra's two lead programs
have been tested in 6 different pre-clinical pain models and have
shown excellent efficacy, without the debilitating side effects that
exist with current pain therapeutics. These unique programs are
targeted at the $20B pain market.
Company: Ichor Medical Systems, Inc.
Media Contact: Tom Gable, Gable PR
Phone: 877-251-3888
E-mail: [email protected]
Web: www.ichorms.com
Ichor has developed a patented one-step electroporation system that
provides rapid, effective and reproducible administration of DNA
drugs and vaccines with minimal operator training or skill. The
integrated and fully-automated Ichor TriGrid(TM) Delivery System
allows the site of injection, placement of electrodes, rate of agent
administration, and timing of electroporation delivery to be
controlled in a user independent fashion. As a result, Ichor's
technology makes the clinical application of electroporation easy,
safe, efficient, and totally compatible with the development and
commercialization of DNA-based products, enhancing DNA uptake by
several orders of magnitude compared to conventional methods of
delivery.
Company: ICON plc
Booth: 2923 & 2925
Ticker Symbol & ICLR on NASDAQ
Exchange:
Media Contact: Erica Hill
Phone: 215-616-3286
E-mail: [email protected]
Web: www.iconclinical.com
ICON is a full service clinical research organization providing a
comprehensive range of clinical services in Phase I-IV clinical
trials to the pharmaceutical, biotechnology and device industries.
With 52 offices in 30 countries across the globe, ICON has the
infrastructure necessary to take on global mega trials, but remains
flexible enough to provide development services on a stand-alone
basis or as part of an integrated "full-service" solution for locally
managed projects.
ICON has one of the most experienced regulatory groups in the
industry, with a proven track record of success in regulatory
submissions and regulatory agency/authority interactions.
Company: IDT
Booth: 1310 and 2133
Media Contact: Chris Henneghan
Phone: 610-269-2100 x237
E-mail: [email protected]
Web: www.idtdna.com
Integrated DNA Technologies, Inc. (IDT) is the largest supplier of
custom nucleic acids in the U.S., serving the areas of academic
research, biotechnology, clinical diagnostics and pharmaceutical
development. IDT's primary business is the manufacturing of custom
DNA and RNA oligonucleotides (oligos) for research applications.
With more than 400 employees, IDT synthesizes and ships an average of
36,000 custom oligos per day and has more than 77,000 customers
worldwide.
IDT is headquartered in Coralville, Iowa, has a production center in
San Diego, California and recently acquired Belgian manufacturer RNA-
TEC.
The company plans to open its third facility later this year in
Leuven, Belgium.
Company: IKERCHEM LTD
Booth: 1085
Phone: (34) 943 015381
E-mail: [email protected]
Web: www.ikerchem.com
IkerChem LTD with a wide expertise on the fields of cycloadditions,
microwave-assisted organic synthesis and computational chemistry
offers the best solutions in your design, synthesis or R&D projects.
IkerChem has confidential collaboration agreements with highly
specialized laboratories to provide support and services in the
following areas:
--Contract R&D
--Custom synthesis
--Computation
Service
Company: Image Reading Center
Booth: 1833
Media Contact: Mark Punyanitya
Phone: 212-523-2487
E-mail: [email protected]
Web: www.imagereadingcenter.com
The Image Reading Center is one of the premier Imaging Core
Laboratories in the world, specializing in the advanced analysis of
MRI, DXA, and CT scans for body composition assessment. The IRC
utilizes high-resolution imaging for whole body (muscle, fat) and
organ specific protocols (cardiac, brain, liver, kidney, spleen, and
pancreas). Study design and conduct, site training and oversight,
data management and quality control services are available for Phase
I/II/III, national and international multi-center studies.
Company: ImmigrationOptions.com - Savitz Law Offices, P.C.
Booth: 1969
Media Contact: Bennett Savitz
Phone: 617-723-7111
E-mail: [email protected]
Web: www.ImmigrationOptions.com
Savitz Law Offices, P.C. (www.ImmigrationOptions.com) provides legal
services and expertise in all areas of immigration law both for
corporate clients and individuals. In addition to obtaining temporary
visas and permanent residence (Green Card) for foreign nationals, we
help clients to file to become naturalized U.S. Citizens, and to
solve specific problems with the Immigration Service or other
government agencies. We have extensive experience working with the
myriad of government entities involved in immigration matters, and
have developed a worldwide network of contacts and other resources in
order to assist our clients on any matter, from the routine to the
extraordinary.
Company: ImmunoGenetix Therapeutics, Inc.
Booth: 2619 (Kansas Pavilion)
Media Contact: Jim Laufenberg
Phone: 888.744.9246
E-mail: [email protected]
Web: www.ImmunoGenetix.com
ImmunoGenetix Therapeutics, Inc. is a biotechnology company developing
advanced DNA immunotherapies for HIV infection. The Company's lead
product candidate, GenePro(TM), is a DNA therapeutic vaccine
incorporating a proprietary DNA construct that yields high levels of
gene expression and non-infectious HIV protein production.
GenePro(TM) induces a robust antibody and cellular immune response in
animal models, without protein or viral vector boosts.
Company: Indy Partnership, The
Booth: 1555
Media Contact: Todd McCall
Phone: 317-965-7989
E-mail: [email protected]
Web: http://www.indypartnership.com
The Indy Partnership is a regional economic development organization
charged with spurring capital investment and job growth. Our staff
aggressively markets the region to bring in new businesses,
investments and jobs. We serve as a regional point-of-contact for
responding to business development inquiries and generating good
sales leads.
Recent Life
Science success:
--Oxford BioSignals have announced plans to move their global
headquarters to Carmel, Indiana
--Beckman Coulter announced that they will be moving a centrifuge
operation to central Indiana
--Indianapolis MSA ranks # 9 in total biosciences employment -
Biotechnology Industry Organization and Battelle Memorial Institute
2007.
Company: Informa Healthcare
Booth: 1813
Media Contact: [email protected]
Phone: 44 20 7017 6980
E-mail: [email protected]
Web: www.informahealthcare.com
Informa Healthcare serves the commercial needs of business leaders,
the research needs of the scientific and academic communities and the
"good practice" needs of healthcare professionals. As the most
dynamic new publishing group serving the life science and medical
markets, we offer a unique range of publishing formats, from major
online databases and news services to research and review journals
and books.
Exhibiting at BIO 2007 this year are Scrip Publishing, PharmaProjects,
BioTechniques and Expert Opinion. Visit our booth 1813 for your FREE
samples and demos or to speak to one of our representatives.
Company: Innovive Inc
Booth: 3034
Media Contact: Jim Fallon
Phone: 858 309 6631
E-mail: [email protected]
Web: www.disposablecages.com
Bring your animal work in house with the Innovive(R) System, the first
fully disposable, irradiated rodent caging solution. Imagine a
Turnkey Vivarium: No Washing, No Autoclaving, No Bottle Filling.
By eliminating cage washing and sterilization the Innovive(R) System
simplifies vivarium operations, eliminates capital equipment
requirements, and significantly reduces animal housing costs.
The Innovive(R) System is a state of the art, modularized, ventilated
racking system that can be located anywhere in your facility without
the need for a wash room. Your researchers will appreciate having
access to their animals when and where they need them.
WWW.DISPOSABLECAGES.COM
Company: Inspire Pharmaceuticals
Booth: NC Pavilion
Ticker Symbol & Nasdaq: ISPH
Exchange:
Media Contact: Jenny Kobin
Phone: 919-287-1219
E-mail: [email protected]
Web: www.inspirepharm.com
Inspire is a biopharmaceutical company dedicated to discovering,
developing and commercializing prescription pharmaceutical products
in disease areas with significant commercial potential and unmet
medical needs.
Inspire employs a U.S. sales force for the promotion of AzaSite(TM)
(azithromycin ophthalmic solution) 1% for bacterial conjunctivitis,
Elestat(R) (epinastine HCl ophthalmic solution) 0.05% for allergic
conjunctivitis and Restasis(R) (cyclosporine ophthalmic emulsion)
0.05% for dry eye. Inspire is focused on the therapeutic areas of
ophthalmology and respiratory/allergy, and is developing products for
dry eye, cystic fibrosis, allergic rhinitis and glaucoma.
Company: Institute of Cancer Research, The
Booth: 1864
Media Contact: Jennifer Hodgson
Phone: 020 7153 5532
E-mail: [email protected]
Web: www.icr.ac.uk
The Institute of Cancer Research works in a unique partnership with
The Royal Marsden NHS Foundation Trust (the world's oldest cancer
hospital) to form Europe's leading and largest comprehensive cancer
centre. The joint research strategy and day to day interactions
between researchers and clinicians ensure that discoveries made in
The Institute's laboratories are swiftly translated into treatment
and care for those affected by cancer. The Enterprise Unit has a
range of collaboration and out licensing opportunities to offer
interested parties, please call by the London Universities stand at
BIO for more information.
Company: Institute of Gene and Brain Science
Booth: Japan Pavilion 2549 / a9
Media Contact: Hirotsugu Watabe
Phone: 81(3)5746-1333
E-mail: [email protected]
Web: http://www.ins-gbs.co.jp/en/index.html
The Institute of Gene and Brain Science is a drug discovery venture
company.
We are developing innovative drugs and therapeutic techniques for two
disease areas (to refer the followings) based on the research and
medical findings of the central nervous system and brain tumors
obtained by Dr. Masahiro Toda, a neurosurgeon, in addition to the
basic medical findings in the field of immunology.
--Regeneration of central nervous system for central nerve damage and
disease (spinal cord injury, cerebral infarction etc.)
--Cancer immune
therapy
Company: Integrated Project Management Company, Inc.
Booth: Massachusetts Pavillion, Booth 533, Stand D25
Media Contact: Claudia Kovitz, CRK Communications LLC
Phone: 847-328-8119
E-mail: [email protected]
Web: www.ipmcinc.com
"Project management" doesn't sound sexy, but it's fast becoming a key
competitive strategy in the biopharmaceutical industry, helping
companies perform more efficiently and effectively. Illustrating this
trend: Integrated Project Management Company, a leading provider of
professional project management services to the life sciences
industry, has quadrupled its biotech and pharmaceutical clientele in
less than five years, with the pace ever-quickening. IPM vice
president Tim Noffke has become a thought-leader on such topics as
streamlining product development (his team helped one global company
cut time-to-market in half), sound alliance management and creative
problem-solving.
Company: INTERES Invest in Spain
Booth: 979
Phone: 34 91 503 5800
E-mail: [email protected]
Web: www.investinspain.org
SPAIN: FOR BIOTECHNOLOGY.
--The Spanish biotechnology sector is growing four times faster than
the EU-15 average.
--Multinational companies such as GSK, Lilly, Merk Serono o MSD have
RD and production centers in Spain.
--Increasing public and private investment and efficient technology
transfer.
INTERES Invest in Spain is the leading government organization that
supports foreign enterprises seeking to set up or expand their
business in Spain. We offer comprehensive, efficient and confidential
consultation at no cost during all stages of the investment process.
Visit our stand at BIO: Your first port of call for investing in
Spain.
Company: inVentiv Health
Booth: 1220
Ticker Symbol & VTIV
Exchange:
Media Contact: Felicia Vonella
Phone: 212.308.7155
E-mail: [email protected]
Web: www.inventivhealth.com
inVentiv Health (NASDAQ: VTIV) is the leading provider of
commercialization and complementary services to the global
pharmaceutical, life sciences and biotechnology industries. inVentiv
delivers its customized clinical, sales, marketing and communications
solutions through its three core business segments: inVentiv
Clinical, inVentiv Communications and inVentiv Commercial. inVentiv
Health currently works with over 200 unique pharmaceutical, biotech
and life sciences clients, including all top 20 global pharmaceutical
companies. For more information, visit www.inventivhealth.com.
Company: Invest in Germany
Media Contact: [email protected]
Phone: (617) 401 2120
E-mail: [email protected]
Web: www.invest-in-germany.com
Invest-in-Germany (IiG) is the German federal investment promotion
agency which informs, assists and consults foreign investors pursuing
business opportunities in Germany. IiG provides full service support
in the implementation of investment decisions, including
comprehensive market analysis, specific information on business
costs, and professional guidance with site analysis. Companies
planning to establish or expand business operations in Germany can
obtain detailed information on tax regulations, regional and federal
financial support, and other aspects of the German corporate
environment. IiG's services are free of charge.
Contact US: Palo Alto, Chicago, Washington and new in Boston: 1
Broadway Cambridge MA 02142, Phone: 6174012120.
Company: Invitrogen
Booth: 239
Ticker Symbol & IVGN
Exchange:
Media Contact: Eric Endicott
Phone: 760-268-7438
E-mail: [email protected]
Web: www.invitrogen.com
Invitrogen Corporation provides products and services that support
academic and government research institutions and pharmaceutical and
biotech companies worldwide in their efforts to improve the human
condition. The company provides essential life science technologies
for disease research, drug discovery, and commercial bioproduction.
Founded in 1987, Invitrogen is headquartered in Carlsbad, California,
and conducts business in more than 70 countries around the world. The
company is celebrating 20 years of accelerating scientific discovery.
Invitrogen globally employs approximately 4,300 scientists and other
professionals and had revenues of more than $1.15 billion in 2006.
Company: Iowa Department of Economic Development
Booth: Iowa Pavilion (1340 - 1361)
Media Contact: Kay Snyder, Communications Manager - Nickelle
Stevens, The Integer Group
Phone: 515-360-2209 / 515-710-2618
E-mail: [email protected]
Web: www.iowalifechanging.com
Iowa offers the ideal expansion solution for bioscience companies. For
investors looking to create beneficial public/private partnerships,
Iowa is the smart choice. And for 1,800 bioscience establishments,
Iowa is already an exciting place to do business. The state is home
to three public universities that are world renowned for their life
sciences research. Iowa leads the nation in the production of
renewable energy and raw biomass. A competitive economic development
incentives program and the opportunity to achieve a balanced personal
life are just a few reasons to take a closer look at Iowa. Stop by
the Iowa Pavilion, or visit www.iowalifechanging.com to learn more.
Company: IPS Research Company
Booth: 2233
Media Contact: Fred Lee
Phone: 405-235 8188
E-mail: [email protected]
Web: www.ipsresearch.com
At IPS Research Company we strive to collect the highest quality data
through consistent good clinical practice. We are proud of our proven
ability to recruit, enroll and retain patients for our clients.
We are continually looking for better ways to serve our clients. With
over 50 years combined research experience, our team of clinicians
takes pride in the services we provide.
At IPS Research Company we strive to build a partnership with our
pharmaceutical clients and our patients to achieve the finest
clinical trial performance.
Company: Isotechnika Inc.
Booth: 720
Ticker Symbol & TSX:ISA
Exchange:
Media Contact: Stephanie Gillis-Paulgaard
Phone: (780) 487 1600
E-mail: [email protected]
Web: www.isotechnika.com
Isotechnika Inc. is a biopharmaceutical company focused on the
discovery and development of novel immunosuppressive therapeutics
that are safer than currently available treatments. Isotechnika's
lead compound is ISA247, a new calcineurin inhibitor with a different
metabolic profile than cyclosporine. ISA247 has completed a Canadian
Phase 3 trial and commenced a European/Canadian Phase 3 trial for the
treatment of moderate to severe psoriasis. A Phase 2b trial using
ISA247 for the prevention of kidney graft rejection has also
commenced in North America. Additionally, Isotechnika has developed
TAFA93, a novel prodrug of the mTOR inhibitor rapamycin. TAFA93 has
successfully completed Phase 1 trials.
Company: ISTO Technologies, Inc.
Media Contact: Mitchell Seyedin Ph.D.
Phone: 314-995-6049
E-mail: 314-995-6025
Web: www.istotech.com
ISTO Technologies, Inc, St. Louis, Missouri, is a clinical stage
orthobiologic company focused on developing differentiated products
for sports medicine and spinal therapy. ISTO's products in
development are intended for repair and regeneration of bone and
cartilage tissues in knee joints and spine. ISTO's lead cartilage
product in phase I/II clinical trials is DeNovo-ET(R) in partnership
with Zimmer, Inc. DeNovo- Et is a living tissue-engineered graft for
the restoration of cartilage defects in the knee. Also under
development are: NuQu(TM) injectable juvenile cartilage cells for
spinal disc repair; and InQu(TM) a tissue-engineered scaffold for
bone and other soft tissue repair.
Company: Iter srl
Booth: 2025 Italy Pavillon
Media Contact: Domenico Piazza
Phone: 39 02 2831161
E-mail: [email protected]
Web: www.iter.it/en
Starting from 2004 bioforum is the meeting between science and
business in Italy. Visit the web site www.bioforum.it/en, look the
masterplan www.bioforum.it/2006/english/conference.htm , the
committee www.bioforum.it/2006/english/committee.htm, previous
editions www.bioforum.it/english/previous.htm.
Since 1989 ITER creates tailoring services for the scientific and
business world. ITER organizes successful Seminars, Congresses and
Exhibitions on innovative topics, such as biotechnologies,
nanotechnologies, computer science and communication by using a rich
and updated database.
ITER edits specialized publication concerning the ICT world dedicated
to the professional field, and publishes services by writing and
printing specialized contents: research, handbooks, books and
brochure, even in limited edition.
Company: Japan External Trade Organization (JETRO)
Booth: 2549
Media Contact: Taku Sato
Phone: (212)-997-0400
E-mail: [email protected]
Web: http://www.jetro.org/
Japan External Trade Organization (JETRO) has organized a Japan
Pavilion, consisting of 32 Japanese biotech companies, at BIO 2007.
We are also offering one-on-one meetings with these companies, to
facilitate future international partnerships and collaborations.
In addition, we have organized two seminars at BIO 2007:
--"Agricultural R&D in Biomass Conversion for Renewable Energy,"
--"Partnering with Japanese Biotech," which will focus on new
opportunities for partnerships.
These seminars will provide in-depth look at current state of Japanese
biotech industry.
For more information on Japan Pavilion participants, and JETRO's
activities at BIO 2007, please check: http://www.jetro.org/bio2007.
Company: J. Calnan & Associates, Inc.
Booth: #533/A19
Media Contact: Michelle Elchaak
Phone: 617-801-0252
E-mail: [email protected]
Web: www.jcalnan.com
J. Calnan & Associates, Inc. (JC&A), headquartered in Quincy, MA with
an office in NYC, is one of New England's leading construction
management firms specializing in world-class pre-construction
consulting, project management, facilities maintenance, and
construction projects in the life science industry. JC&A has excelled
at working in challenging GMP environments including occupied spaces,
challenging user groups, and strict security requirements and
demanding schedules. Our team will ensure that the critical issues
regarding material selection and availability, quality assurance,
safety, security and milestones are understood.
Our clients include Wyeth Pharmaceuticals, Acceleron Pharma, Draper
Laboratory, Parexel and Millipore Corporation. Visit website:
www.jcalnan.com.
Company: Joule Scientific Staffing Solutions
Booth: 1967
Media Contact: Mary Jane Martin
Phone: 800-382-0382 x418
E-mail: [email protected]
Web: www.joulescientific.com
For over a decade, Joule has defined the market for Scientific
Staffing. Joule Scientific delivers the best solution for each
biotechnology, pharmaceutical, chemical, and clinical research
organization. Joule has developed the perfect process for finding
that perfect employee. From the discovery phase to strategy and
planning, through execution and onto results, there is a single
mission - providing the perfect employee. Our systematic yet
customizable method relies heavily on the experience of trained
professionals and technology based tools. This market-defining
process and service not only provides positive results today, but
anticipates our clients' needs for tomorrow. The Right Match is in
Our DNA. www.joulescientific.com
Company: Journal of BIOLaw & Business, The
Booth: Massachusetts Pavillion #533/C5
Media Contact: Robin JR Blatt
Phone: 617.633.5522
E-mail: [email protected]
Web: www.biolawbusiness.com
THE JOURNAL OF BIOLAW & BUSINESS (JB&B) is the leading international
publication focused on critical topics in 21st century life sciences
law, business, regulatory and policy matters. It's reading for those
who want to stay ahead of the curve.
Established in 1997 and published quarterly, the The JB&B Collection
also consists of thematic BioLaw & Business Supplements and JB&B
International Series with country-specific supplements. On-line
access, electronic updates, notification of events are available
through JB&B News Service.
From emerging business models or regulatory and legal trends...to
debates and advances in stem cells, biogenerics, pricing policies,
genomics and pharmaceutical research... JB&B reports on it all. JB&B
contributing editors, advisors and authors are world experts,
providing original analysis and tools for life science executives
Visit www.biolawbusiness.com for subscriptions, editorial, advertising
or contact [email protected] or JB&B Customer Service at
1.888.732.6732.
Company: JTC Corporation
Booth: 2533 - Singapore Pavilion
Media Contact: Ms Carin Leong
Phone: 65 68833062
E-mail: [email protected]
Web: www.jtc.gov.sg; www.one-north.com
JTC Corporation (JTC) is the lead agency in Singapore to develop key
industrial facilities and vibrant industrial space. Currently, JTC
has under its management many developments including four wafer fab
parks and an advanced display park, two business parks, a chemicals
hub at Jurong Island, as well as logistics hubs for aerospace,
chemical and general warehousing industries.
Catering to the biomedical sciences industry, JTC has developed the
Biopolis, a 185,000 sqm, seven-building research complex, which is a
hotspot for biomedical research talent, and the Tuas Biomedical Park,
a premier manufacturing hub with key infrastructure provisions for
biomedical companies.
Company: KBI BioPharma, Inc.
Booth: 2373
Phone: (919) 479-9898
E-mail: [email protected]
Web: www.kbibiopharma.com
KBI Biopharma, a leader in contract biopharmaceutical development,
enhances drug value by partnering with our clients to develop
products more rapidly and efficiently.
We develop scalable, robust processes which result in stable, active
products. Our clients benefit from faster time to market and lower
cost of manufactured goods.
Our innovative team has a broad range of product development and
proven problem-solving experience, with an emphasis in formulation
and analytical development. We are known for our unique application
of biophysical and biochemical protein characterization and our
collaborative approach, our emphasis on close communication and our
ability to accelerate milestone target dates.
Company: KenkouKagakuKenkyu-kai.Co,.Ltd.
Booth: 2549 B-2
Media Contact: Takeno Dan
Phone: 81-774-32-6282
E-mail: [email protected]
Web: http://www.kekkan-bijin.jp
KenkouKagakuKenkyu-kai.Co,.Ltd. (http://www.kekkan-bijin.jp/)is a
health science research company focused in health check machine of
Video Microscope "Kekkanbijin".
Kekkanbijin can tell blood flow conditions at a glance without drawing
blood. Observation of the status of blood capillary shape and
cleanliness of tissue fluid is useful as a means to measure health.
It also finds application in the field of health products as a sales
tool providing realistic before and after comparisons.
Company: Kentucky Cabinet for Economic Development
Booth: 1907
Media Contact: Paul Boisvert
Phone: 502-564-4300 x3223
E-mail: [email protected]
Web: www.ThinkKentucky.com/dci
The Kentucky Economic Development Cabinet and several of Kentucky's
leading biotech start-up companies will be at BIO 2007 in Booth 1907.
Experts will be on hand to talk about shovel-ready development sites,
workforce training, incentive programs, community profiles, small
business assistance and other resources. For high-techs looking to
locate or relocate their companies, we are the only state to
specifically match both federal Phase 1 and Phase 2 SBIR-STTR awards.
We're already matching federal Phase 1 awards made after January 1,
2006, and will start matching Phase 2 awards beginning July 1, 2007.
More information is available at www.ThinkKentucky.com/dci
Company: KeyGene Science Co Ltd
Booth: 2341
Phone: 82-11-90142389
E-mail: [email protected]
Web: www.keygene.co.kr
KeyGene Science is developing new Diagnostic Cancer Biomarkers that
make early detection of cancers possible by an investigational blood
test in a simple, convenient and economic way. Simple blood test can
be a useful tool of mass screening for cancers.
HepaCheck, a new diagnostic sandwich ELISA kit, can identify liver
cancer with an accuracy of greater than 80% through estimating a
protein in serum by use of antibodies obtained from oncogene HCCR.
Other novel biomarkers against Leukemia, Thyroid cancer, Colon cancer,
Breast cancer, Cervical Cancer and Lung Cancer possessing potential
diagnostic capability at laboratory tests are under process of
validation.
Patent is registered in Japan, Korea, U.S.A. and pending in some
countries. This will protect HepaCheck and other potential
diagnostics from duplication by competitors. Marketing strategies are
partnering by regional licensing contract.
Company: KeyNeurotek Pharmaceuticals AG
Booth: 575
Media Contact: Dr. Frank Striggow
Phone: 49 391 6117220
E-mail: [email protected]
Web: www.keyneurotek.de
KeyNeurotek is localized in Magdeburg, Germany, one of the leading
centres of neuroscience in Europe. KeyNeurotek pursues a number of
drug candidates in various preclinical and clinical stages. The most
advanced compound, KN38-7271, a cannabinoid receptor agonist, is in
Phase IIa in comatose patients with traumatic brain injury. The
company has unique functional and tissue-based high throughput
screening platforms for compatible ex vivo and in vivo studies
(TELOMICSTM). Based on its know-how, KeyNeurotek develops innovative
therapies for the treatment of various neurodegenerative diseases of
the central nervous system, such as traumatic brain injury (TBI),
stroke, and Alzheimer's disease.
Company: KGK Synergize Inc.
Booth: 507 Ontario Pavilion
Media Contact: Kristen Reynolds, Associate Director, Marketing &
Sales
Phone: 519-438-9374 Ext. 222
E-mail: [email protected]
Web: www.kgksynergize.com
KGK Synergize Inc. is a Canadian biotechnology company having two
divisions; 1) a fast growing contract research organization (CRO) for
third parties 2) a new product development (NPD) division.
Both ISO 9001:2000 and GLP certified, the CRO division offers a wide
range of in-house research services to the client including
analytical testing, cell screening, toxicity studies, in vivo models
and human clinical trials.
The NPD division develops nutraceutical and functional food products
to the point where they are ready to manufacture and market.
Currently, products are in the areas of cardiovascular, type II
diabetes, inflammation and anti-cancer.
Company: Kingmed Diag
Booth: 1633, 1637
Media Contact: Joyce Deng
Phone: 86 20 22283222 ext. 320
E-mail: [email protected]
Web: www.kingmed.com.cn
Kingmed is the largest and the first clinical laboratory that is
operated with international standard (ISO17025 & CAP) in China and is
the first medical institute that won "Quality award" in China
Kingmed's core Services include:
--Clinical laboratory testing: the nation's leading provider of
clinical laboratory testing, information and services in China. Now
have 1000 test items.
--Clinical trials: to be the central laboratory for phase I through
phase IV clinical trials that serves internationally
--Physical examination: expertise for annual check-up, about 20000
persons/ year.
--Food and hygiene testing: to help consumer goods industries to
develop, implement and evaluate the safety and quality of operation
process
Company: Knobbe Martens Olson & Bear
Booth: 1469
Media Contact: Sara McKibben (Director of Business Development)
Phone: 949-760-0404
E-mail: [email protected]
Web: www.kmob.com
Knobbe Martens represents clients in all areas of intellectual
property law and litigation. Clients include public and private
companies at various stages of growth, from start-up to the Fortune
500 worldwide. Founded in 1962, the firm is one of the largest
intellectual property law firms in the United States with over 180
lawyers firm wide. Knobbe Martens has been recognized in surveys for
excellence in all aspects of intellectual property law. In 2007, the
firm was ranked #1 for growth in patent litigation and in the top 10
for number of patent litigation cases in a nationwide survey
conducted by IP Law 360. In addition, several members of the firm
have been voted among the world's leading intellectual property
lawyers. www.kmob.com
Company: Krakow Lifescience Park - Jagellionian Center of
Innovation Ltd POLAND
Booth: 1654
Media Contact: Lisette Mermod (London)
Phone: 44 7968 970 942 / 48 50 600 6620
E-mail: [email protected] (Poland)
Web: www.jci.pl
Pharmaceutical companies from all over the world invest in Krakow
attracted by local economic strengths and a rich cultural
environment. With its R&D potential, Krakow is steadily becoming
Poland's lifescience leader. Supported by the Lifescience Cluster the
JCI Ltd seeks to:
--become the single point of contact for biobusiness relationship
development and progressing business and scientific collaborations,
--promote Poland's first-to-market biobusiness property offer to a
global market
--facilitate introductions to Krakow's organisations
For preliminary information regarding the benefits and opportunities
for direct development and investment in Krakow's special economic
zones please contact Mr Pawel Blachno at [email protected]
Company: Kringle Pharma, Inc.
Booth: 2549
Media Contact: Kei Nakanishi, Manager, Business Development
Phone: 81-6-6831-3330
E-mail: [email protected]
Web: www.kringle-pharma.com
Kringle Pharma, Inc. is a venture biopharmaceutical company
established in 2001. Our corporate mission is to provide solution for
unmet medical needs by developing cutting edge medical treatment for
patients suffering from cancer or incurable diseases through clinical
development of Hepatocyte Growth Factor (HGF) and NK4. To achieve its
goal, Kringle is now undertaking two R&D projects; 1) clinical
development of recombinant human HGF protein for repair and
regenerative therapy and 2) clinical development of NK4 protein/gene
as a novel cancer treatment. Kringle is seeking to conclude a
strategic alliance with pharmaceutical companies that is interested
in innovative medical seeds.
Company: LabScores
Booth: 2633
Media Contact: PC Sijmons
Phone: 31-653-246-095
E-mail: [email protected]
Web: www.labscores.com
LabScores(R) relational databases can contain almost any data you need
to store in your biotech company and spans CRM-HRM-LIMS-GMP
functionalities all into one seamless application. LabsScores is
available in modules that fit your requirements at any stage of your
company. LabScores runs on FileMaker(R) Pro software, one of the
worlds most reliable database platforms available and can be accessed
by up to 250 concurrent client computers. The modules are unlocked,
allowing users to implement changes in a dynamic business and
research environment quickly and at low cost, taking advantage of the
user-friendly FileMaker programming capabilities.
Company: Lehigh Valley Economic Development Corporation
Booth: 001440
Media Contact: Joe McDermott
Phone: 610-266-6775
E-mail: [email protected]
Web: www.lehighvalley.org
Lehigh Valley Economic Development Corporation (LVEDC), is a one-stop,
full-service business and economic development agency. Coordinating
with state, county, and municipal governments, chambers of commerce,
industry organizations, educational institutions and utilities, the
award-winning LVEDC streamlines the relocation and expansion process
for businesses. LVEDC also administers the Southside Bethlehem KIZ.
The KIZ program is a key element of Governor Rendell's economic
stimulus package. By focusing talent and resources, KIZs build
synergies among emerging technology companies. Entrepreneurs find
ready resources for workforce and financial assistance. The KIZ
program seeks to reverse the brain drain of talented students and
entrepreneurs.
Company: LentiKats
Web: www.lentikats.eu
----------------------------------------------------
"Lentikats&q
uot; is a technology focused on the development and
implementation of immobilized cells and enzymes. This technology is
based on the immobilization of biomass or enzymes into a
polyvinylalcohol carrier. Our main goal is the global implementation
of Lentikats Biotechnology in fermentation, biotransformations and
bioconversions processes. This primarily concerns the development,
production and application of Lentikats Biocatalysts for industrial
applications in distillery (bioethanol production), waste water
treatment (pollutants biodegradations), pharmaceutics and food
industry (robust biocatalysts production).
Company: Limerick NeuroSciences, Inc.
Media Contact: Debra Bannister
Phone: 530 676-8001
E-mail: [email protected]
Web: www.limerickneuro.com
Limerick NeuroSciences, Inc. is a venture-funded biopharmaceutical
company focused on the development of safe and potent pharmaceuticals
with attenuated neurotoxicity. The company was founded by the
scientific team of Franz Hefti, Ph.D., Leslie Benet, Ph.D., Ving Lee,
Ph.D., Cynthia McCormick, M.D., and Wendye R. Robbins, M.D. Limerick
began operations 2006, with venture funding from Arch Venture
Partners, Sevin Rosen Funds, and Altitude Life Science Partners, as
well as others. Limerick's first clinical compound successfully
completed an exploratory clinical trial and is continuing
development. Dr. Ving Lee, will represent the company during BIO's
2007 Business Forum on Wednesday morning, May 9.
Company: Locus Pharmaceuticals, Inc.
Media Contact: Robert Dickey IV
Phone: 215-358-2006
E-mail: [email protected]
Web: www.locuspharma.com
----------------------------------------------------
Locus is a world leader in computational drug design. The Company's
core technology is a fragment-based, computational approach, which
Locus has combined with highly integrated medicinal chemistry,
crystallography and biology capabilities to create a unique drug
design and development platform. Locus is using its capabilities to
develop its own compounds and has also entered into drug
design/development collaborations with pharmaceutical partners. All
of the Company's internal development programs emanate from its
computational technology and are focused on oral drug therapies,
principally in cancer and inflammation.
Company: MacroChem Corporation
Booth: 533/A15
Ticker Symbol & OTCBB: MACM.OB
Exchange:
Media Contact: Jordan Silverstein, The Investor Relations Group
Phone: 212-825-3210
E-mail: [email protected]
Web: www.macrochem.com
MacroChem (OTCBB: MACM.OB) is a specialty pharmaceutical company that
develops and seeks to commercialize pharmaceutical products.
Currently, our portfolio of proprietary product candidates is based
on our drug delivery technologies: SEPA(R), MacroDerm(TM), and
DermaPass(TM). Our patented SEPA topical drug delivery technology
(SEPA is an acronym for "Soft Enhancement of Percutaneous
Absorption," where "soft" refers to the reversibility of the skin
effect of the technology, and "percutaneous" means "through the
skin") enhances the efficiency and rate of diffusion of drugs into
and through the skin.
Company: Magnisense
Booth: 1307 - France Pavilion
Media Contact: Luc Lenglet
Phone: 33 (0)6 10 92 02 24
E-mail: [email protected]
Web: www.magnisense.com
Magnisense develops and markets a new generation of immunoassays for
human and animal diagnostics, food safety and environmental
protection. These innovative immunoassays are based on magnetic bead
markers, which deliver the accuracy of laboratory testing with the
ease of use of rapid test methods currently on the market.
Magnisense is developing two application areas:
MIAstrip(TM): Point of care testing with a single dose, producing
objective, quantifiable and traceable results via a portable reader
for cardiac, tetanus, microbial or viral infection markers among
others.
MIAflo(TM): Disposable cartridges for detection of bacterial
contamination in food products, e.g. Listeria and Salmonella, or in
water, e.g. Legionella, with a sensitivity that brings a significant
reduction in testing time.
Company: Miami-Dade Beacon Council, The
Booth: 1743
Media Contact: Xavier Gonzalez
Phone: 305-579-1341
E-mail: [email protected]
Web: www.beaconcouncil.com
The Beacon Council, Miami-Dade County's official economic development
partnership, is a not-for-profit, public-private organization that
focuses on job creation and economic growth.
The Beacon Council works to keep Miami-Dade, which is home to world-
class life science research institutions and life science companies,
in the forefront of today's life science industry.
The Beacon Council's free and confidential services include Market
Research and Demographics Information; Business Costs Information;
Site Selection Assistance; Permitting Facilitation; and Access to
Labor Training and Financial and Incentive Programs.
Company: Malaysian Biotechnology Corporation Sdn Bhd
Booth: 170 - Malaysia Pavilion
Media Contact: Norashikin Abdullah Shan
Phone: 603-2116 5588 / 6017-226 3411
E-mail: [email protected]
Web: www.biotechcorp.com.my
BiotechCorp is the implementation agency leading the development of
the biotechnology industry in Malaysia. Our focus areas are
healthcare, agriculture and industrial biotechnology. Malaysia has a
unique set of value propositions conducive to biotechnology
development and we seek investment, collaboration, partnerships and
R&D opportunities.
Company: Marks & Clerk
Booth: 1774
Media Contact: Alan Ritchie
Phone: 44 (0) 779 565 1712 OR 44 (0) 207 420 103
E-mail: [email protected]
Web: www.marks-clerk.com
Marks & Clerk is one of the world's leading firms of patent and trade
mark attorneys. We also have an associated intellectual property law
firm, Marks & Clerk Solicitors. Our highly experienced bioscience
professionals provide strategic guidance on intellectual property
across all disciplines to clients worldwide. The members of our
Bioscience Group all have relevant technical backgrounds, and in many
cases, a higher qualification in specialist areas such as molecular
biology, pharmaceuticals, genomics, immunology, cell biology,
structural biology, veterinary science, virology, stem cells,
diagnostics, proteomics, bioinformatics, vaccines, nanotechnology,
medical devices and plant variety protection.
Company: Massachusetts Biotechnology Council (MBC)
Booth: 533 - Massachusetts Pavilion
Media Contact: John Lacey, Director of Communications
Phone: 617-674-5143
E-mail: [email protected]
Web: www.massbio.org
The Massachusetts Biotechnology Council (MBC), founded in 1985, is a
not-for-profit trade organization that provides services and support
for the Massachusetts biotechnology industry. The MBC is committed to
advancing the development of critical new science, technology and
medicines that benefit people worldwide. Representing over 500
companies, academic institutions and service organizations involved
in life sciences, the MBC works with public leaders to advance policy
and promote education, while providing programs for its members.
Note to Editors: Business Wire's PressPass allows you to create free, custom Web, RSS, and email-based news feeds from more than 160 industry options, dozens of subject categories and thousands of geographic preferences as well as by specific company filters. In addition, PressPass subscribers have access to exclusive content, experts, company profiles, email alerts, survey services and other media services.
Note to Event Organizers: Add your trade show, conference, or event to http://www.tradeshownews.com, Business Wire's online event calendar. For information, email [email protected].
[ Back To TMCnet.com's Homepage ]
|
